G. Martignoni - Concepedia

Author

G. Martignoni

Also Known As

G Martignoni, G. C. Martignoni, G. Martignoni, G.C. Martignoni, G.Carlo Martignoni, Giancarlo Martignoni, Guido Martignoni

Publications

688

Citations

H-Index

Concepts

All Affiliations

University of Milan Ospedale San Carlo Azienda Ospedaliero Universitaria Ospedali Riuniti Azienda Ospedaliera Treviglio

About

G. Martignoni is an author at University of Milan specializing in medicine, colorectal cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	409
2	Pharmacology	3	3	181
3	Gastroenterology	2	2	206
4	Pathology	2	2	206
5	Surgical Oncology	1	1	131

G. Martignoni

Publications

593

Citations

H-Index

Page 1

	Year	Citations
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma Gerardo Rosati, G. Ambrosini, Sandro Barni, Annals of Oncology Surgical OncologyGastrointestinal OncologyCancer ScreeningColorectal SurgeryMedicine	2015	131
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. Stefano Cascinu, Roberto Labianca, Paolo Alessandroni, Journal of Clinical Oncology	1997	103
Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema Angelo Agostoni, Marco Cicardi, G. Martignoni, Journal of Allergy and Clinical Immunology MedicineHereditary Angioedema	1980	97
Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. A Agostoni, Luigi Bergamaschini, G. Martignoni, PubMed Laryngeal EdemaTranslational MedicineMedicineHereditary AngioedemaSide Effects	1980	76
Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer) Roberto Labianca, G. Pancera, Enrico Aitini, Annals of Oncology Gastrointestinal OncologyGastrointestinal PharmacologyMedicinePharmacologyGastroenterology	1991	75
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) Stefano Cascinu, Mario Scartozzi, Roberto Labianca, British Journal of Cancer	2004	69
High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study Roberto Labianca, Stefano Cascinu, L. Frontini, Annals of Oncology OncologyGastrointestinal OncologyMedicineColorectal CancerPharmacotherapy	1997	30
HEREDITARY ANGIONEUROTIC ŒDEMA A Agostoni, G. Martignoni The Lancet Hereditary Angioneurotic œDemaAngiologyVascular MalformationVascular Surgery	1973	12

Page 1